- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產品
- 聯(lián)系我們
BI-2536是一種有效的Plk1抑制劑,無細胞試驗中IC50為0.83 nM。BI-2536可抑制 Bromodomain 4 (BRD4) ,其Kd值為37 nM,并有效地抑制 c-Myc 的表達。BI-2536可誘導凋亡而減弱自噬。Phase 2。
BI 2536 Chemical Structure
CAS: 755038-02-9
相關靶點 | PLK1 PLK2 PLK3 PLK4 | 點擊展開 |
---|---|---|
相關產品 | Volasertib Rigosertib (ON-01910) GSK461364 Onvansertib (NMS-P937) SBE 13 HCl Ro3280 CFI-400945 HMN-214 MLN0905 Poloxin | 點擊展開 |
相關化合物庫 | 激酶抑制劑庫 PI3K/Akt 抑制劑庫 MAPK抑制劑庫 DNA損傷/ DNA修復化合物庫 細胞周期化合物庫 | 點擊展開 |
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
Y79 | Apoptosis Assay | 1-50 nM | 12/24 h | induced apoptosis which can be enhanced by HT | 24366665 |
WER-Rb-1 | Apoptosis Assay | 1-50 nM | 12/24 h | induced apoptosis which can be enhanced by HT | 24366665 |
SF188 | Growth Inhibition Assay | 10-100 nM | 24-96 h | inhibits cell growth in both time- and concentration- depedent manner | 23887645 |
T98G | Growth Inhibition Assay | 10-100 nM | 24-96 h | inhibits cell growth in concentration- depedent manner | 23887645 |
MCF7? | Function Assay | 100 nM | 1 h | reduces the induction of?Greb1,?Sgk1,?Ps2,?Serpina3, and?Wisp2 | 23770244 |
MDA-MB-468 | Apoptosis Assay | 1/5/10 nM | 24/48/72 h | induces apoptosis in a dose-dependent manner | 23144294 |
MCF10A | Apoptosis Assay | 1/5/10 nM | 24/48/72 h | induces apoptosis in a dose-dependent manner | 23144294 |
Huh-7 | Growth Inhibition Assay | 1/10/100/1000 nM | 48 h | decreases the cell viability dose-dependently | 22745587 |
Daoy? | Growth Inhibition Assay | 1.875-240 nM | 72 h | IC50=5 nM | 22390279 |
ONS-76 | Growth Inhibition Assay | 1.875-240 nM | 72 h | IC50=7.5 nM | 22390279 |
SUM 149 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
MDA-MB-231 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
HR5 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
BT-474-M1 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
AU565 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
T47D | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
MCF7 | Growth Inhibition Assay | 0-100 nM | 72 h | inhibits the cell viability in a dose-dependent mannar | 22309939 |
HCT116p53(+/+) | Growth Inhibition Assay | 10-1000 nM | 24/48 h | inhibits cell proliferation completely at 25 nM | 22262171 |
HCT116p53(-/-) | Growth Inhibition Assay | 10-1000 nM | 24/48 h | inhibits cell proliferation completely at 25 nM | 22262171 |
HeLa? | Growth Inhibition Assay | 10-100 nM | 48 h | IC50=52.9 nM | 22080235 |
HeLa? | Growth Inhibition Assay | 10-100 nM | 72 h | IC50=50.5 nM | 22080235 |
786-O | Growth Inhibition Assay | 5-80 nM | 96 h | suppresses the proliferation in a dose-dependent manner with IC50?values of 2 to 20 nM | 21642374 |
A498 | Growth Inhibition Assay | 5-80 nM | 96 h | suppresses the proliferation in a dose-dependent manner with IC50?values of 2 to 20 nM | 21642374 |
ACHN | Growth Inhibition Assay | 5-80 nM | 96 h | suppresses the proliferation in a dose-dependent manner with IC50?values of 2 to 20 nM | 21642374 |
Caki-1 | Growth Inhibition Assay | 5-80 nM | 96 h | suppresses the proliferation in a dose-dependent manner with IC50?values of 2 to 20 nM | 21642374 |
SN12C | Growth Inhibition Assay | 5-80 nM | 96 h | suppresses the proliferation in a dose-dependent manner with IC50?values of 2 to 20 nM | 21642374 |
HMC-1.1 | Growth Inhibition Assay | 1-1000 nM | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
HMC-1.2 | Growth Inhibition Assay | 1-1000 nM | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
C2 | Growth Inhibition Assay | 1-1000 nM | 72 h | inhibits the cell proliferation in a dose-dependent manne | 21242189 |
CHP-212 | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
IMR-32 | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
Kelly | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SH-EP | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SH-SY5Y | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SK-N-AS | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
SK-N-BE | Growth Inhibition Assay | 1-125 nM | 24-120 h | inhibits the cell proliferation in both time- and dose-dependent manne | 21169242 |
KG1 | Growth Inhibition Assay | 1/10/100 nM | 72 h | inhibits the cell proliferation in both time- and dose-dependent manne | 19458358 |
U937 | Growth Inhibition Assay | 1/10/100 nM | 72 h | inhibits the cell proliferation in both time- and dose-dependent manne | 19458358 |
CAL62 | Growth Inhibition Assay | 0.1-100 nM | 72 h | EC50=1.4 nM | 19223553 |
OCUT-1 | Growth Inhibition Assay | 0.1-100 nM | 72 h | EC50=2.3 nM | 19223553 |
8505C | Growth Inhibition Assay | 0.1-100 nM | 72 h | EC50=3.2 nM | 19223553 |
ACT-1 | Growth Inhibition Assay | 0.1-100 nM | 72 h | EC50=5.4 nM | 19223553 |
SW1736 | Growth Inhibition Assay | 0.1-100 nM | 72 h | EC50=5.6 nM | 19223553 |
DU145 | Apoptosis assay | 100 nM | 24 hrs | Induction of apoptosis in human DU145 cells assessed as increase in PARP cleavage at 100 nM after 24 hrs by immunoblotting method | 25685941 |
HeLa | Function assay | 100 nM | 18 hrs | Induction of monopolar mitotic spindles in human HeLa cells at 100 nM incubated for 18 hrs by indirect immunofluorescence microscopy | 25685941 |
HeLa | Apoptosis assay | 100 nM | 24 hrs | Induction of apoptosis in human HeLa cells assessed as increase in PARP cleavage at 100 nM after 24 hrs by immunoblotting method | 25685941 |
PC3 | Function assay | 100 nM | 18 hrs | Induction of monopolar mitotic spindles in human PC3 cells at 100 nM incubated for 18 hrs by indirect immunofluorescence microscopy | 25685941 |
HeLa | Function assay | 100 nM | Inhibition of PLK1 Thr210 phosphorylation in human HeLa cells at 100 nM by immunoblotting method | 25685941 | |
DU145 | Function assay | 100 nM | Inhibition of PLK1 protein accumulation in human DU145 cells at 100 nM by immunoblotting method | 25685941 | |
HeLa | Function assay | 100 nM | Inhibition of PLK1 protein accumulation in human HeLa cells at 100 nM by immunoblotting method | 25685941 | |
DU145 | Function assay | 100 nM | Inhibition of PLK1 Thr210 phosphorylation in human DU145 cells at 100 nM by immunoblotting method | 25685941 | |
JURKAT | Growth Inhibition Assay | 24 h | IC50=416.66 nM | 24519995 | |
MOLT-4 | Growth Inhibition Assay | 24 h | IC50=2853.5 nM | 24519995 | |
REH | Growth Inhibition Assay | 24 h | IC50=287.68 nM | 24519995 | |
NALM-6 | Growth Inhibition Assay | 24 h | IC50=34330 nM | 24519995 | |
RS 4;11 | Growth Inhibition Assay | 24 h | IC50=519.05 nM | 24519995 | |
697 | Growth Inhibition Assay | 24 h | IC50=2107.1 nM | 24519995 | |
SIL-ALL | Growth Inhibition Assay | 24 h | IC50=199.77 nM | 24519995 | |
CEM | Growth Inhibition Assay | 24 h | IC50=52.18 nM | 24519995 | |
P12 | Growth Inhibition Assay | 24 h | IC50=39.27 nM | 24519995 | |
NALM-16 | Growth Inhibition Assay | 24 h | IC50=96.28 nM | 24519995 | |
JURKAT | Growth Inhibition Assay | 48 h | IC50=14.84 nM | 24519995 | |
MOLT-4 | Growth Inhibition Assay | 48 h | IC50=26.6 nM | 24519995 | |
REH | Growth Inhibition Assay | 48 h | IC50=44.71 nM | 24519995 | |
NALM-6 | Growth Inhibition Assay | 48 h | IC50=23.26 nM | 24519995 | |
RS 4;11 | Growth Inhibition Assay | 48 h | IC50=164.28 nM | 24519995 | |
697 | Growth Inhibition Assay | 48 h | IC50=305.3 nM | 24519995 | |
SIL-ALL | Growth Inhibition Assay | 48 h | IC50=74.62 nM | 24519995 | |
CEM | Growth Inhibition Assay | 48 h | IC50=24.55 nM | 24519995 | |
P12 | Growth Inhibition Assay | 48 h | IC50=18.46 nM | 24519995 | |
NALM-16 | Growth Inhibition Assay | 48 h | IC50=63.24 nM | 24519995 | |
JURKAT | Growth Inhibition Assay | 72 h | IC50=3.65 nM | 24519995 | |
MOLT-4 | Growth Inhibition Assay | 72 h | IC50=7.39 nM | 24519995 | |
REH | Growth Inhibition Assay | 72 h | IC50=16.01 nM | 24519995 | |
NALM-6 | Growth Inhibition Assay | 72 h | IC50=1.78 nM | 24519995 | |
RS 4;11 | Growth Inhibition Assay | 72 h | IC50=4.38 nM | 24519995 | |
697 | Growth Inhibition Assay | 72 h | IC50=74.28 nM | 24519995 | |
SIL-ALL | Growth Inhibition Assay | 72 h | IC50=7.2 nM | 24519995 | |
CEM | Growth Inhibition Assay | 72 h | IC50=5.42 nM | 24519995 | |
P12 | Growth Inhibition Assay | 72 h | IC50=6.37 nM | 24519995 | |
NALM-16 | Growth Inhibition Assay | 72 h | IC50=77.73 nM | 24519995 | |
GBC | Growth Inhibition Assay | 72 h | IC50=14.78 nM | 21965739 | |
GB-CL-1 | Growth Inhibition Assay | 72 h | IC50=5.22 nM | 21965739 | |
Mz-ChA-2 | Growth Inhibition Assay | 72 h | IC50=3.31 nM | 21965739 | |
TGBC1-TKB | Growth Inhibition Assay | 144 h | IC50=6.72 nM | 21965739 | |
Wittier | Growth Inhibition Assay | 72 h | IC50=3.26 nM | 21965739 | |
H-1 | Growth Inhibition Assay | 72 h | IC50=9.54 nM | 21965739 | |
HuH-28 | Growth Inhibition Assay | 72 h | IC50=11.19 nM | 21965739 | |
NEC | Growth Inhibition Assay | 72 h | IC50=9.98 nM | 21965739 | |
REB | Growth Inhibition Assay | 72 h | IC50=13.51 nM | 21965739 | |
CC-LP-1 | Growth Inhibition Assay | 72 h | IC50=5.84 nM | 21965739 | |
CC-SW-1 | Growth Inhibition Assay | 72 h | IC50=9.55 nM | 21965739 | |
EGI-1 | Growth Inhibition Assay | 72 h | IC50=10.72 nM | 21965739 | |
Sk-ChA-1 | Growth Inhibition Assay | 72 h | IC50=17.2 nM | 21965739 | |
TFK-1 | Growth Inhibition Assay | 72 h | IC50=13.45 nM | 21965739 | |
HEK293 | Function assay | 1 hr | Binding affinity to PLK1 (unknown origin) expressed in HEK293 cells after 1 hr by proprietary competition assay, Ki = 0.00022 μM. | 26191363 | |
HEK293T | Antiproliferative assay | 72 hrs | Antiproliferative activity against HEK293T cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. | 28792760 | |
MDA-MB-231 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MDA-MB-231 cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. | 28792760 | |
MM1S | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MM1S cells measured after 72 hrs by CellTiter-Blue assay, IC50 = 0.001 μM. | 28792760 | |
TY82 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human TY82 cells after 72 hrs by CCK8 assay, IC50 = 0.001 μM. | 28586718 | |
NMC-797 | Cytotoxicity assay | 3 days | Cytotoxicity against BRD4 dependent human NMC-797 cells assessed as cell viability after 3 days by ATPlite assay, IC50 = 0.0107 μM. | 26985285 | |
MV4-11 | Cytotoxicity assay | 24 hrs | Cytotoxicity against human MV4-11 cells after 24 hrs by CellTiter-Blue assay, GI50 = 0.0152 μM. | 26191363 | |
BL21(DE3) | Function assay | 60 mins | Inhibition of recombinant human N-terminal His6-tagged BRD4 expressed in Escherichia coli BL21(DE3) cells using biotinylated histone H4 peptide as substrate after 60 mins by AlphaScreen assay, IC50 = 0.025 μM. | 28195723 | |
HuH7 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human HuH7 cells after 72 hrs by CCK8 assay, GI50 = 0.028 μM. | 29220793 | |
HeLa | Antiproliferative assay | 72 hrs | Antiproliferative activity against human HeLa cells after 72 hrs by CCK8 assay, GI50 = 0.034 μM. | 29220793 | |
HL60 | Cytotoxicity assay | 3 days | Cytotoxicity against BRD4 dependent human HL60 cells assessed as cell viability after 3 days by ATPlite assay, IC50 = 0.0365 μM. | 26985285 | |
A549 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay, GI50 = 0.057 μM. | 29220793 | |
MCF7 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human MCF7 cells after 72 hrs by CCK8 assay, GI50 = 0.067 μM. | 29220793 | |
K562 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human K562 cells after 72 hrs by CCK8 assay, GI50 = 0.068 μM. | 29220793 | |
MDA-MB-23 | Function assay | 6 hrs | Inhibition of PLK1 in human MDA-MB-23 cells assessed as decrease in TCTP phosphorylation after 6 hrs by Western blot method, IC50 = 0.1 μM. | 28792760 | |
HEK293T | Function assay | 6 hrs | Inhibition of PLK1 in HEK293T cells assessed as decrease in TCTP phosphorylation after 6 hrs by Western blot method, IC50 = 0.1 μM. | 28792760 | |
NCI-H1975 | Antiproliferative assay | 72 hrs | Antiproliferative activity against human NCI-H1975 cells after 72 hrs by CCK8 assay, GI50 = 0.23 μM. | 29220793 | |
BL21(DE3) | Function assay | 4 hrs | Inhibition of JQ1-FITC binding to His6-tagged BRD4-BD1 (unknown origin) expressed in Escherichia coli BL21 (DE3)-codon plus-RIL cells incubated in dark for 4 hrs by fluorescence anisotropy assay, IC50 = 0.25 μM. | 28586718 | |
A3-KAW | Growth Inhibition Assay | IC50=0.25341 μM | SANGER | ||
CTB-1 | Growth Inhibition Assay | IC50=0.24493 μM | SANGER | ||
LB1047-RCC | Growth Inhibition Assay | IC50=0.2441 μM | SANGER | ||
OPM-2 | Growth Inhibition Assay | IC50=0.23882 μM | SANGER | ||
NCI-H345 | Growth Inhibition Assay | IC50=0.23805 μM | SANGER | ||
SIG-M5 | Growth Inhibition Assay | IC50=0.22727 μM | SANGER | ||
BC-1 | Growth Inhibition Assay | IC50=0.22616 μM | SANGER | ||
GR-ST | Growth Inhibition Assay | IC50=0.21488 μM | SANGER | ||
NCI-H1436 | Growth Inhibition Assay | IC50=0.21464 μM | SANGER | ||
HH | Growth Inhibition Assay | IC50=0.21405 μM | SANGER | ||
GAK | Growth Inhibition Assay | IC50=0.21189 μM | SANGER | ||
NCI-H720 | Growth Inhibition Assay | IC50=0.20525 μM | SANGER | ||
JiyoyeP-2003 | Growth Inhibition Assay | IC50=0.20477 μM | SANGER | ||
EVSA-T | Growth Inhibition Assay | IC50=0.20312 μM | SANGER | ||
UACC-257 | Growth Inhibition Assay | IC50=0.19947 μM | SANGER | ||
LC4-1 | Growth Inhibition Assay | IC50=0.19502 μM | SANGER | ||
KARPAS-299 | Growth Inhibition Assay | IC50=0.19241 μM | SANGER | ||
NCI-H2141 | Growth Inhibition Assay | IC50=0.19011 μM | SANGER | ||
SNB75 | Growth Inhibition Assay | IC50=0.18824 μM | SANGER | ||
L-428 | Growth Inhibition Assay | IC50=0.18813 μM | SANGER | ||
NB6 | Growth Inhibition Assay | IC50=0.18566 μM | SANGER | ||
COLO-320-HSR | Growth Inhibition Assay | IC50=0.18154 μM | SANGER | ||
DOHH-2 | Growth Inhibition Assay | IC50=0.17672 μM | SANGER | ||
ARH-77 | Growth Inhibition Assay | IC50=0.17379 μM | SANGER | ||
LOXIMVI | Growth Inhibition Assay | IC50=0.16949 μM | SANGER | ||
HCE-T | Growth Inhibition Assay | IC50=0.16504 μM | SANGER | ||
NCI-H64 | Growth Inhibition Assay | IC50=0.16347 μM | SANGER | ||
SU-DHL-1 | Growth Inhibition Assay | IC50=0.16206 μM | SANGER | ||
MC116 | Growth Inhibition Assay | IC50=0.16158 μM | SANGER | ||
LS-123 | Growth Inhibition Assay | IC50=0.15917 μM | SANGER | ||
KINGS-1 | Growth Inhibition Assay | IC50=0.1591 μM | SANGER | ||
COLO-684 | Growth Inhibition Assay | IC50=0.15721 μM | SANGER | ||
SCLC-21H | Growth Inhibition Assay | IC50=0.15702 μM | SANGER | ||
TGBC24TKB | Growth Inhibition Assay | IC50=0.15659 μM | SANGER | ||
EM-2 | Growth Inhibition Assay | IC50=0.15467 μM | SANGER | ||
SH-4 | Growth Inhibition Assay | IC50=0.15466 μM | SANGER | ||
NB5 | Growth Inhibition Assay | IC50=0.15462 μM | SANGER | ||
NKM-1 | Growth Inhibition Assay | IC50=0.14906 μM | SANGER | ||
COR-L88 | Growth Inhibition Assay | IC50=0.14802 μM | SANGER | ||
GB-1 | Growth Inhibition Assay | IC50=0.14526 μM | SANGER | ||
CAL-148 | Growth Inhibition Assay | IC50=0.14483 μM | SANGER | ||
LP-1 | Growth Inhibition Assay | IC50=0.1424 μM | SANGER | ||
MLMA | Growth Inhibition Assay | IC50=0.14167 μM | SANGER | ||
NCCIT | Growth Inhibition Assay | IC50=0.13939 μM | SANGER | ||
NCI-H747 | Growth Inhibition Assay | IC50=0.137 μM | SANGER | ||
KP-N-RT-BM-1 | Growth Inhibition Assay | IC50=0.13612 μM | SANGER | ||
HT | Growth Inhibition Assay | IC50=0.13574 μM | SANGER | ||
LAMA-84 | Growth Inhibition Assay | IC50=0.13187 μM | SANGER | ||
EW-3 | Growth Inhibition Assay | IC50=0.12893 μM | SANGER | ||
no-11 | Growth Inhibition Assay | IC50=0.12869 μM | SANGER | ||
RPMI-6666 | Growth Inhibition Assay | IC50=0.12743 μM | SANGER | ||
SR | Growth Inhibition Assay | IC50=0.12441 μM | SANGER | ||
SK-PN-DW | Growth Inhibition Assay | IC50=0.12287 μM | SANGER | ||
MZ7-mel | Growth Inhibition Assay | IC50=0.12237 μM | SANGER | ||
RPMI-8226 | Growth Inhibition Assay | IC50=0.12052 μM | SANGER | ||
KU812 | Growth Inhibition Assay | IC50=0.12044 μM | SANGER | ||
TK10 | Growth Inhibition Assay | IC50=0.11728 μM | SANGER | ||
K052 | Growth Inhibition Assay | IC50=0.11712 μM | SANGER | ||
EoL-1-cell | Growth Inhibition Assay | IC50=0.11672 μM | SANGER | ||
NCI-H524 | Growth Inhibition Assay | IC50=0.11274 μM | SANGER | ||
BV-173 | Growth Inhibition Assay | IC50=0.11243 μM | SANGER | ||
L-363 | Growth Inhibition Assay | IC50=0.11079 μM | SANGER | ||
MZ2-MEL | Growth Inhibition Assay | IC50=0.1105 μM | SANGER | ||
JAR | Growth Inhibition Assay | IC50=0.10925 μM | SANGER | ||
K-562 | Growth Inhibition Assay | IC50=0.10858 μM | SANGER | ||
HD-MY-Z | Growth Inhibition Assay | IC50=0.10856 μM | SANGER | ||
NCI-SNU-16 | Growth Inhibition Assay | IC50=0.10742 μM | SANGER | ||
L-540 | Growth Inhibition Assay | IC50=0.10708 μM | SANGER | ||
NCI-H1304 | Growth Inhibition Assay | IC50=0.10594 μM | SANGER | ||
NEC8 | Growth Inhibition Assay | IC50=0.10525 μM | SANGER | ||
NCI-H526 | Growth Inhibition Assay | IC50=0.1044 μM | SANGER | ||
DU-4475 | Growth Inhibition Assay | IC50=0.10407 μM | SANGER | ||
BB65-RCC | Growth Inhibition Assay | IC50=0.10294 μM | SANGER | ||
NCI-H1882 | Growth Inhibition Assay | IC50=0.09809 μM | SANGER | ||
NCI-H2126 | Growth Inhibition Assay | IC50=0.09791 μM | SANGER | ||
BC-3 | Growth Inhibition Assay | IC50=0.09662 μM | SANGER | ||
Calu-6 | Growth Inhibition Assay | IC50=0.09598 μM | SANGER | ||
COR-L279 | Growth Inhibition Assay | IC50=0.09556 μM | SANGER | ||
NCI-H446 | Growth Inhibition Assay | IC50=0.09462 μM | SANGER | ||
ONS-76 | Growth Inhibition Assay | IC50=0.09276 μM | SANGER | ||
NCI-SNU-5 | Growth Inhibition Assay | IC50=0.09258 μM | SANGER | ||
MOLT-4 | Growth Inhibition Assay | IC50=0.08983 μM | SANGER | ||
DG-75 | Growth Inhibition Assay | IC50=0.08922 μM | SANGER | ||
A253 | Growth Inhibition Assay | IC50=0.08822 μM | SANGER | ||
KGN | Growth Inhibition Assay | IC50=0.08759 μM | SANGER | ||
NCI-H1694 | Growth Inhibition Assay | IC50=0.08744 μM | SANGER | ||
LU-134-A | Growth Inhibition Assay | IC50=0.08708 μM | SANGER | ||
HEL | Growth Inhibition Assay | IC50=0.08668 μM | SANGER | ||
LB831-BLC | Growth Inhibition Assay | IC50=0.08561 μM | SANGER | ||
NCI-H510A | Growth Inhibition Assay | IC50=0.08336 μM | SANGER | ||
Daudi | Growth Inhibition Assay | IC50=0.08256 μM | SANGER | ||
Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=0.08225 μM | SANGER | ||
CMK | Growth Inhibition Assay | IC50=0.08225 μM | SANGER | ||
KNS-42 | Growth Inhibition Assay | IC50=0.08161 μM | SANGER | ||
MOLT-16 | Growth Inhibition Assay | IC50=0.08121 μM | SANGER | ||
MONO-MAC-6 | Growth Inhibition Assay | IC50=0.07986 μM | SANGER | ||
SW962 | Growth Inhibition Assay | IC50=0.07839 μM | SANGER | ||
NCI-H187 | Growth Inhibition Assay | IC50=0.07726 μM | SANGER | ||
DMS-114 | Growth Inhibition Assay | IC50=0.07528 μM | SANGER | ||
U-266 | Growth Inhibition Assay | IC50=0.07497 μM | SANGER | ||
NCI-H1581 | Growth Inhibition Assay | IC50=0.07478 μM | SANGER | ||
VA-ES-BJ | Growth Inhibition Assay | IC50=0.07475 μM | SANGER | ||
GI-ME-N | Growth Inhibition Assay | IC50=0.07286 μM | SANGER | ||
IST-SL2 | Growth Inhibition Assay | IC50=0.07004 μM | SANGER | ||
RXF393 | Growth Inhibition Assay | IC50=0.06764 μM | SANGER | ||
KS-1 | Growth Inhibition Assay | IC50=0.06748 μM | SANGER | ||
NB1 | Growth Inhibition Assay | IC50=0.06613 μM | SANGER | ||
CPC-N | Growth Inhibition Assay | IC50=0.06524 μM | SANGER | ||
BB30-HNC | Growth Inhibition Assay | IC50=0.06436 μM | SANGER | ||
ATN-1 | Growth Inhibition Assay | IC50=0.06345 μM | SANGER | ||
MHH-PREB-1 | Growth Inhibition Assay | IC50=0.06319 μM | SANGER | ||
RS4-11 | Growth Inhibition Assay | IC50=0.06304 μM | SANGER | ||
SF268 | Growth Inhibition Assay | IC50=0.06286 μM | SANGER | ||
KM-H2 | Growth Inhibition Assay | IC50=0.06221 μM | SANGER | ||
HT-144 | Growth Inhibition Assay | IC50=0.0613 μM | SANGER | ||
LB771-HNC | Growth Inhibition Assay | IC50=0.05979 μM | SANGER | ||
NALM-6 | Growth Inhibition Assay | IC50=0.05973 μM | SANGER | ||
8-MG-BA | Growth Inhibition Assay | IC50=0.05851 μM | SANGER | ||
EW-1 | Growth Inhibition Assay | IC50=0.05837 μM | SANGER | ||
SK-LMS-1 | Growth Inhibition Assay | IC50=0.05805 μM | SANGER | ||
TE-6 | Growth Inhibition Assay | IC50=0.05722 μM | SANGER | ||
DEL | Growth Inhibition Assay | IC50=0.05709 μM | SANGER | ||
TALL-1 | Growth Inhibition Assay | IC50=0.05708 μM | SANGER | ||
KY821 | Growth Inhibition Assay | IC50=0.05632 μM | SANGER | ||
TE-12 | Growth Inhibition Assay | IC50=0.05613 μM | SANGER | ||
HC-1 | Growth Inhibition Assay | IC50=0.05597 μM | SANGER | ||
SJSA-1 | Growth Inhibition Assay | IC50=0.0552 μM | SANGER | ||
CTV-1 | Growth Inhibition Assay | IC50=0.05502 μM | SANGER | ||
no-10 | Growth Inhibition Assay | IC50=0.05474 μM | SANGER | ||
ML-2 | Growth Inhibition Assay | IC50=0.05414 μM | SANGER | ||
TGBC1TKB | Growth Inhibition Assay | IC50=0.05405 μM | SANGER | ||
KARPAS-45 | Growth Inhibition Assay | IC50=0.05358 μM | SANGER | ||
NB17 | Growth Inhibition Assay | IC50=0.05207 μM | SANGER | ||
DJM-1 | Growth Inhibition Assay | IC50=0.05142 μM | SANGER | ||
TE-5 | Growth Inhibition Assay | IC50=0.05063 μM | SANGER | ||
IMR-5 | Growth Inhibition Assay | IC50=0.05021 μM | SANGER | ||
MFH-ino | Growth Inhibition Assay | IC50=0.05003 μM | SANGER | ||
MS-1 | Growth Inhibition Assay | IC50=0.04701 μM | SANGER | ||
LU-139 | Growth Inhibition Assay | IC50=0.04442 μM | SANGER | ||
IST-MEL1 | Growth Inhibition Assay | IC50=0.04442 μM | SANGER | ||
HCC1599 | Growth Inhibition Assay | IC50=0.04258 μM | SANGER | ||
MOLT-13 | Growth Inhibition Assay | IC50=0.04238 μM | SANGER | ||
PF-382 | Growth Inhibition Assay | IC50=0.04198 μM | SANGER | ||
MZ1-PC | Growth Inhibition Assay | IC50=0.04127 μM | SANGER | ||
BL-41 | Growth Inhibition Assay | IC50=0.04125 μM | SANGER | ||
KP-N-YS | Growth Inhibition Assay | IC50=0.04085 μM | SANGER | ||
OVCAR-4 | Growth Inhibition Assay | IC50=0.04059 μM | SANGER | ||
TE-10 | Growth Inhibition Assay | IC50=0.04046 μM | SANGER | ||
SW982 | Growth Inhibition Assay | IC50=0.0379 μM | SANGER | ||
SK-UT-1 | Growth Inhibition Assay | IC50=0.03774 μM | SANGER | ||
A101D | Growth Inhibition Assay | IC50=0.03748 μM | SANGER | ||
Becker | Growth Inhibition Assay | IC50=0.03555 μM | SANGER | ||
SK-NEP-1 | Growth Inhibition Assay | IC50=0.03499 μM | SANGER | ||
ES4 | Growth Inhibition Assay | IC50=0.03463 μM | SANGER | ||
NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=0.03399 μM | SANGER | ||
NCI-H82 | Growth Inhibition Assay | IC50=0.03343 μM | SANGER | ||
ST486 | Growth Inhibition Assay | IC50=0.03337 μM | SANGER | ||
NB13 | Growth Inhibition Assay | IC50=0.03316 μM | SANGER | ||
LB647-SCLC | Growth Inhibition Assay | IC50=0.03195 μM | SANGER | ||
GT3TKB | Growth Inhibition Assay | IC50=0.02953 μM | SANGER | ||
ES6 | Growth Inhibition Assay | IC50=0.02881 μM | SANGER | ||
BL-70 | Growth Inhibition Assay | IC50=0.02857 μM | SANGER | ||
TE-11 | Growth Inhibition Assay | IC50=0.02809 μM | SANGER | ||
NCI-H1355 | Growth Inhibition Assay | IC50=0.02783 μM | SANGER | ||
KE-37 | Growth Inhibition Assay | IC50=0.02741 μM | SANGER | ||
BE-13 | Growth Inhibition Assay | IC50=0.0274 μM | SANGER | ||
TE-15 | Growth Inhibition Assay | IC50=0.02738 μM | SANGER | ||
ETK-1 | Growth Inhibition Assay | IC50=0.02736 μM | SANGER | ||
HCE-4 | Growth Inhibition Assay | IC50=0.02682 μM | SANGER | ||
NCI-H1648 | Growth Inhibition Assay | IC50=0.02647 μM | SANGER | ||
HUTU-80 | Growth Inhibition Assay | IC50=0.02624 μM | SANGER | ||
CCRF-CEM | Growth Inhibition Assay | IC50=0.02543 μM | SANGER | ||
TE-1 | Growth Inhibition Assay | IC50=0.02512 μM | SANGER | ||
RPMI-8402 | Growth Inhibition Assay | IC50=0.02508 μM | SANGER | ||
HOP-62 | Growth Inhibition Assay | IC50=0.0242 μM | SANGER | ||
KALS-1 | Growth Inhibition Assay | IC50=0.02338 μM | SANGER | ||
KURAMOCHI | Growth Inhibition Assay | IC50=0.02285 μM | SANGER | ||
TE-9 | Growth Inhibition Assay | IC50=0.02261 μM | SANGER | ||
A388 | Growth Inhibition Assay | IC50=0.02227 μM | SANGER | ||
A4-Fuk | Growth Inhibition Assay | IC50=0.02218 μM | SANGER | ||
NOS-1 | Growth Inhibition Assay | IC50=0.02093 μM | SANGER | ||
LOUCY | Growth Inhibition Assay | IC50=0.0205 μM | SANGER | ||
RKO | Growth Inhibition Assay | IC50=0.01987 μM | SANGER | ||
OCUB-M | Growth Inhibition Assay | IC50=0.01826 μM | SANGER | ||
LXF-289 | Growth Inhibition Assay | IC50=0.0177 μM | SANGER | ||
RL95-2 | Growth Inhibition Assay | IC50=0.01738 μM | SANGER | ||
SW954 | Growth Inhibition Assay | IC50=0.01705 μM | SANGER | ||
IA-LM | Growth Inhibition Assay | IC50=0.01688 μM | SANGER | ||
NCI-H1963 | Growth Inhibition Assay | IC50=0.01673 μM | SANGER | ||
697 | Growth Inhibition Assay | IC50=0.01668 μM | SANGER | ||
CESS | Growth Inhibition Assay | IC50=0.01602 μM | SANGER | ||
SNU-C2B | Growth Inhibition Assay | IC50=0.01526 μM | SANGER | ||
ES8 | Growth Inhibition Assay | IC50=0.01494 μM | SANGER | ||
LS-411N | Growth Inhibition Assay | IC50=0.01407 μM | SANGER | ||
GI-1 | Growth Inhibition Assay | IC50=0.01383 μM | SANGER | ||
KM12 | Growth Inhibition Assay | IC50=0.01348 μM | SANGER | ||
EW-16 | Growth Inhibition Assay | IC50=0.01336 μM | SANGER | ||
ALL-PO | Growth Inhibition Assay | IC50=0.013 μM | SANGER | ||
LC-2-ad | Growth Inhibition Assay | IC50=0.01093 μM | SANGER | ||
TE-8 | Growth Inhibition Assay | IC50=0.00941 μM | SANGER | ||
ACN | Growth Inhibition Assay | IC50=0.00843 μM | SANGER | ||
PSN1 | Growth Inhibition Assay | IC50=0.00776 μM | SANGER | ||
SF126 | Growth Inhibition Assay | IC50=0.25383 μM | SANGER | ||
KARPAS-422 | Growth Inhibition Assay | IC50=0.25435 μM | SANGER | ||
MEG-01 | Growth Inhibition Assay | IC50=0.25673 μM | SANGER | ||
NCI-H209 | Growth Inhibition Assay | IC50=0.26374 μM | SANGER | ||
SBC-1 | Growth Inhibition Assay | IC50=0.265 μM | SANGER | ||
K5 | Growth Inhibition Assay | IC50=0.26984 μM | SANGER | ||
QIMR-WIL | Growth Inhibition Assay | IC50=0.27155 μM | SANGER | ||
NMC-G1 | Growth Inhibition Assay | IC50=0.28217 μM | SANGER | ||
IST-MES1 | Growth Inhibition Assay | IC50=0.29238 μM | SANGER | ||
SW684 | Growth Inhibition Assay | IC50=0.30047 μM | SANGER | ||
MV-4-11 | Growth Inhibition Assay | IC50=0.30788 μM | SANGER | ||
LAN-6 | Growth Inhibition Assay | IC50=0.31572 μM | SANGER | ||
RH-1 | Growth Inhibition Assay | IC50=0.31871 μM | SANGER | ||
CP66-MEL | Growth Inhibition Assay | IC50=0.31878 μM | SANGER | ||
EC-GI-10 | Growth Inhibition Assay | IC50=0.32987 μM | SANGER | ||
GDM-1 | Growth Inhibition Assay | IC50=0.33059 μM | SANGER | ||
IST-SL1 | Growth Inhibition Assay | IC50=0.34914 μM | SANGER | ||
KMOE-2 | Growth Inhibition Assay | IC50=0.35175 μM | SANGER | ||
OS-RC-2 | Growth Inhibition Assay | IC50=0.35544 μM | SANGER | ||
HDLM-2 | Growth Inhibition Assay | IC50=0.37814 μM | SANGER | ||
DSH1 | Growth Inhibition Assay | IC50=0.38631 μM | SANGER | ||
LS-1034 | Growth Inhibition Assay | IC50=0.38954 μM | SANGER | ||
LB373-MEL-D | Growth Inhibition Assay | IC50=0.39197 μM | SANGER | ||
GOTO | Growth Inhibition Assay | IC50=0.42118 μM | SANGER | ||
MRK-nu-1 | Growth Inhibition Assay | IC50=0.42205 μM | SANGER | ||
SK-MM-2 | Growth Inhibition Assay | IC50=0.43442 μM | SANGER | ||
BOKU | Growth Inhibition Assay | IC50=0.43792 μM | SANGER | ||
NOMO-1 | Growth Inhibition Assay | IC50=0.4386 μM | SANGER | ||
J-RT3-T3-5 | Growth Inhibition Assay | IC50=0.44878 μM | SANGER | ||
COLO-668 | Growth Inhibition Assay | IC50=0.45668 μM | SANGER | ||
SF539 | Growth Inhibition Assay | IC50=0.48684 μM | SANGER | ||
LB2518-MEL | Growth Inhibition Assay | IC50=0.49703 μM | SANGER | ||
TE-441-T | Growth Inhibition Assay | IC50=0.5012 μM | SANGER | ||
MDA-MB-134-VI | Growth Inhibition Assay | IC50=0.50921 μM | SANGER | ||
SCC-3 | Growth Inhibition Assay | IC50=0.51873 μM | SANGER | ||
KLE | Growth Inhibition Assay | IC50=0.52171 μM | SANGER | ||
LB2241-RCC | Growth Inhibition Assay | IC50=0.52525 μM | SANGER | ||
NCI-H1417 | Growth Inhibition Assay | IC50=0.53435 μM | SANGER | ||
NCI-H2081 | Growth Inhibition Assay | IC50=0.58611 μM | SANGER | ||
NCI-H1522 | Growth Inhibition Assay | IC50=0.59383 μM | SANGER | ||
NCI-H889 | Growth Inhibition Assay | IC50=0.59844 μM | SANGER | ||
CGTH-W-1 | Growth Inhibition Assay | IC50=0.60755 μM | SANGER | ||
EB-3 | Growth Inhibition Assay | IC50=0.61153 μM | SANGER | ||
D-336MG | Growth Inhibition Assay | IC50=0.61791 μM | SANGER | ||
LC-1F | Growth Inhibition Assay | IC50=0.62592 μM | SANGER | ||
MHH-NB-11 | Growth Inhibition Assay | IC50=0.63801 μM | SANGER | ||
SK-N-FI | Growth Inhibition Assay | IC50=0.6391 μM | SANGER | ||
NCI-H69 | Growth Inhibition Assay | IC50=0.64879 μM | SANGER | ||
SCH | Growth Inhibition Assay | IC50=0.66023 μM | SANGER | ||
LS-513 | Growth Inhibition Assay | IC50=0.67259 μM | SANGER | ||
CP67-MEL | Growth Inhibition Assay | IC50=0.67596 μM | SANGER | ||
GCIY | Growth Inhibition Assay | IC50=0.70363 μM | SANGER | ||
SHP-77 | Growth Inhibition Assay | IC50=0.70734 μM | SANGER | ||
EHEB | Growth Inhibition Assay | IC50=0.71854 μM | SANGER | ||
D-247MG | Growth Inhibition Assay | IC50=0.73232 μM | SANGER | ||
Raji | Growth Inhibition Assay | IC50=0.74989 μM | SANGER | ||
MPP-89 | Growth Inhibition Assay | IC50=0.75978 μM | SANGER | ||
EKVX | Growth Inhibition Assay | IC50=0.79073 μM | SANGER | ||
HCC2218 | Growth Inhibition Assay | IC50=0.79131 μM | SANGER | ||
KNS-81-FD | Growth Inhibition Assay | IC50=0.81011 μM | SANGER | ||
HCC2157 | Growth Inhibition Assay | IC50=0.84951 μM | SANGER | ||
BT-474 | Growth Inhibition Assay | IC50=0.88854 μM | SANGER | ||
NCI-H748 | Growth Inhibition Assay | IC50=0.912 μM | SANGER | ||
EW-24 | Growth Inhibition Assay | IC50=0.92002 μM | SANGER | ||
D-263MG | Growth Inhibition Assay | IC50=0.94512 μM | SANGER | ||
OMC-1 | Growth Inhibition Assay | IC50=0.96373 μM | SANGER | ||
NCI-H2196 | Growth Inhibition Assay | IC50=0.97777 μM | SANGER | ||
HAL-01 | Growth Inhibition Assay | IC50=0.99872 μM | SANGER | ||
NCI-H2107 | Growth Inhibition Assay | IC50=1.01854 μM | SANGER | ||
LB996-RCC | Growth Inhibition Assay | IC50=1.08051 μM | SANGER | ||
NCI-H1395 | Growth Inhibition Assay | IC50=1.1067 μM | SANGER | ||
CHP-126 | Growth Inhibition Assay | IC50=1.16199 μM | SANGER | ||
NB69 | Growth Inhibition Assay | IC50=1.26148 μM | SANGER | ||
CAS-1 | Growth Inhibition Assay | IC50=1.34231 μM | SANGER | ||
JVM-3 | Growth Inhibition Assay | IC50=1.47855 μM | SANGER | ||
DMS-153 | Growth Inhibition Assay | IC50=1.57674 μM | SANGER | ||
SK-MEL-2 | Growth Inhibition Assay | IC50=1.71789 μM | SANGER | ||
NCI-H1155 | Growth Inhibition Assay | IC50=1.73676 μM | SANGER | ||
NCI-H1092 | Growth Inhibition Assay | IC50=1.76182 μM | SANGER | ||
LU-165 | Growth Inhibition Assay | IC50=1.86476 μM | SANGER | ||
HL-60 | Growth Inhibition Assay | IC50=1.99908 μM | SANGER | ||
REH | Growth Inhibition Assay | IC50=2.00582 μM | SANGER | ||
JVM-2 | Growth Inhibition Assay | IC50=2.06135 μM | SANGER | ||
MN-60 | Growth Inhibition Assay | IC50=2.17308 μM | SANGER | ||
SCC-15 | Growth Inhibition Assay | IC50=2.2027 μM | SANGER | ||
SNU-C1 | Growth Inhibition Assay | IC50=2.21343 μM | SANGER | ||
SK-MEL-1 | Growth Inhibition Assay | IC50=2.32047 μM | SANGER | ||
TGW | Growth Inhibition Assay | IC50=2.35027 μM | SANGER | ||
CA46 | Growth Inhibition Assay | IC50=2.75967 μM | SANGER | ||
NCI-H23 | Growth Inhibition Assay | IC50=2.80791 μM | SANGER | ||
MMAC-SF | Growth Inhibition Assay | IC50=2.86628 μM | SANGER | ||
NCI-H2171 | Growth Inhibition Assay | IC50=3.03448 μM | SANGER | ||
A704 | Growth Inhibition Assay | IC50=3.14194 μM | SANGER | ||
DB | Growth Inhibition Assay | IC50=3.25576 μM | SANGER | ||
NCI-H719 | Growth Inhibition Assay | IC50=3.30384 μM | SANGER | ||
MC-CAR | Growth Inhibition Assay | IC50=3.54817 μM | SANGER | ||
SIMA | Growth Inhibition Assay | IC50=3.58416 μM | SANGER | ||
SW872 | Growth Inhibition Assay | IC50=3.78101 μM | SANGER | ||
HCC1187 | Growth Inhibition Assay | IC50=3.78315 μM | SANGER | ||
EW-13 | Growth Inhibition Assay | IC50=3.83417 μM | SANGER | ||
NCI-SNU-1 | Growth Inhibition Assay | IC50=4.21999 μM | SANGER | ||
NCI-H226 | Growth Inhibition Assay | IC50=4.33606 μM | SANGER | ||
RPMI-8866 | Growth Inhibition Assay | IC50=4.36029 μM | SANGER | ||
OCI-AML2 | Growth Inhibition Assay | IC50=4.5523 μM | SANGER | ||
LU-65 | Growth Inhibition Assay | IC50=4.93033 μM | SANGER | ||
SK-N-DZ | Growth Inhibition Assay | IC50=5.63465 μM | SANGER | ||
NB14 | Growth Inhibition Assay | IC50=5.97135 μM | SANGER | ||
COLO-829 | Growth Inhibition Assay | IC50=6.33359 μM | SANGER | ||
MHH-CALL-2 | Growth Inhibition Assay | IC50=6.51508 μM | SANGER | ||
NCI-H1770 | Growth Inhibition Assay | IC50=6.66904 μM | SANGER | ||
ECC4 | Growth Inhibition Assay | IC50=6.82179 μM | SANGER | ||
A498 | Growth Inhibition Assay | IC50=6.87192 μM | SANGER | ||
DMS-79 | Growth Inhibition Assay | IC50=7.04512 μM | SANGER | ||
P30-OHK | Growth Inhibition Assay | IC50=7.21906 μM | SANGER | ||
D-502MG | Growth Inhibition Assay | IC50=7.9836 μM | SANGER | ||
RCC10RGB | Growth Inhibition Assay | IC50=8.0628 μM | SANGER | ||
U-698-M | Growth Inhibition Assay | IC50=8.29226 μM | SANGER | ||
BB49-HNC | Growth Inhibition Assay | IC50=9.42265 μM | SANGER | ||
ES1 | Growth Inhibition Assay | IC50=9.68956 μM | SANGER | ||
MFM-223 | Growth Inhibition Assay | IC50=10.9927 μM | SANGER | ||
C2BBe1 | Growth Inhibition Assay | IC50=11.3523 μM | SANGER | ||
EB2 | Growth Inhibition Assay | IC50=12.6881 μM | SANGER | ||
C8166 | Growth Inhibition Assay | IC50=13.8303 μM | SANGER | ||
ES3 | Growth Inhibition Assay | IC50=13.9977 μM | SANGER | ||
NCI-H1650 | Growth Inhibition Assay | IC50=16.3765 μM | SANGER | ||
Mo-T | Growth Inhibition Assay | IC50=17.4029 μM | SANGER | ||
NB7 | Growth Inhibition Assay | IC50=17.7467 μM | SANGER | ||
ES7 | Growth Inhibition Assay | IC50=19.5507 μM | SANGER | ||
ES5 | Growth Inhibition Assay | IC50=21.7671 μM | SANGER | ||
MSTO-211H | Growth Inhibition Assay | IC50=21.8858 μM | SANGER | ||
U-87-MG | Growth Inhibition Assay | IC50=25.1966 μM | SANGER | ||
THP-1 | Growth Inhibition Assay | IC50=29.7201 μM | SANGER | ||
NB10 | Growth Inhibition Assay | IC50=30.2694 μM | SANGER | ||
NH-12 | Growth Inhibition Assay | IC50=33.2017 μM | SANGER | ||
COLO-824 | Growth Inhibition Assay | IC50=34.1006 μM | SANGER | ||
SKM-1 | Growth Inhibition Assay | IC50=37.8422 μM | SANGER | ||
NCI-H1838 | Growth Inhibition Assay | IC50=38.3797 μM | SANGER | ||
RL | Growth Inhibition Assay | IC50=39.2477 μM | SANGER | ||
COLO-800 | Growth Inhibition Assay | IC50=40.0773 μM | SANGER | ||
KG-1 | Growth Inhibition Assay | IC50=40.8955 μM | SANGER | ||
TUR | Growth Inhibition Assay | IC50=41.6399 μM | SANGER | ||
LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=41.9017 μM | SANGER | ||
NCI-H322M | Growth Inhibition Assay | IC50=42.5984 μM | SANGER | ||
LNCaP? | Growth Inhibition Assay | IC50=91.3 nM | 25505174 | ||
C4-2 | Growth Inhibition Assay | IC50=8 nM | 25505174 | ||
G7 | Growth Inhibition Assay | IC50=3.3 nM | 24204733 | ||
G166 | Growth Inhibition Assay | IC50=7.0 nM | 24204733 | ||
CB660 | Growth Inhibition Assay | IC50=6.4 nM | 24204733 | ||
CB1117 | Growth Inhibition Assay | IC50=15.6 nM | 24204733 | ||
KB-3-1 | Growth Inhibition Assay | IC50=1.48 ± 0.53 nM | 23962445 | ||
KB-8-5-11 | Growth Inhibition Assay | IC50=5.01 ± 2.01 nM | 23962445 | ||
KB-C-1 | Growth Inhibition Assay | IC50=16.76 ± 4.51 nM | 23962445 | ||
KB-V-1 | Growth Inhibition Assay | IC50=281.24 ± 31.57 nM | 23962445 | ||
OVCAR-8 | Growth Inhibition Assay | IC50=7.19 ± 3.60 nM | 23962445 | ||
NCI-ADR-RES | Growth Inhibition Assay | IC50=1273.30 ± 191.20 nM | 23962445 | ||
MCF7 | Growth Inhibition Assay | IC50=5.11 ± 1.47 nM | 23962445 | ||
MCF7-FLV1000 | Growth Inhibition Assay | IC50=393.18 ± 74.83 nM | 23962445 | ||
S1 | Growth Inhibition Assay | IC50=24.30 ± 4.75 nM | 23962445 | ||
S1-M1-80 | Growth Inhibition Assay | IC50=261.06 ± 48.25 nM | 23962445 | ||
CORL-23/P | Growth Inhibition Assay | IC50=4.38 ± 1.25 nM | 23962445 | ||
CORL-23/R | Growth Inhibition Assay | IC50=5.16 ± 1.83 nM | 23962445 | ||
NIH3T3 | Growth Inhibition Assay | IC50=40.60 ± 4.97 nM | 23962445 | ||
NIH3T3-G185 | Growth Inhibition Assay | IC50=2413.40 ± 423.66 nM | 23962445 | ||
pcDNA-HEK293 | Growth Inhibition Assay | IC50=2.75 ± 0.67 nM | 23962445 | ||
MDR19-HEK293 | Growth Inhibition Assay | IC50=85.50 ± 13.67 nM | 23962445 | ||
R482-HEK293 | Growth Inhibition Assay | IC50=25.97 ± 4.95 nM | 23962445 | ||
MRP1-HEK293 | Growth Inhibition Assay | IC50=2.99 ± 1.49 nM | 23962445 | ||
DU145 | Growth Inhibition Assay | IC50~60 nM | 23884428 | ||
LNCaP? | Growth Inhibition Assay | IC50~75 nM | 23884428 | ||
PC3 | Growth Inhibition Assay | IC50~175 nM | 23884428 | ||
RT4 | Growth Inhibition Assay | IC50=27.21 nM | 23792639 | ||
5637 | Growth Inhibition Assay | IC50=45.47 nM | 23792639 | ||
T24 | Growth Inhibition Assay | IC50=79.12 nM | 23792639 | ||
KB-V1? | Growth Inhibition Assay | IC50=3.92 μM | 23593196 | ||
Hec50co | Growth Inhibition Assay | IC50=5 nM | 23146687 | ||
BL21(DE3) | Function assay | Inhibition of human N-terminal His6-tagged BRD4-BD1 (44 to 168 residues) expressed in Escherichia coli BL21 (DE3) cells using protein thermal shift dye as fluorescence probe by differential scanning fluorimetry, IC50 = 0.025 μM. | 28586718 | ||
TC32 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 29435139 | ||
U-2 OS | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 29435139 | ||
A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 29435139 | ||
Saos-2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 29435139 | ||
BT-37 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 29435139 | ||
RD | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 29435139 | ||
SK-N-SH | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 29435139 | ||
BT-12 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 29435139 | ||
NB1643 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 29435139 | ||
OHS-50 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 29435139 | ||
BT-12 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells | 29435139 | ||
LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells | 29435139 | ||
Fibroblast cells | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 29435139 | ||
NB-EBc1 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells | 29435139 | ||
SK-N-SH | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells | 29435139 | ||
A673 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells) | 29435139 | ||
BT-37 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells | 29435139 | ||
MG 63(6-TG R) | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells | 29435139 | ||
Fibroblast cells | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells | 29435139 | ||
OHS-50 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells | 29435139 | ||
RD | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells | 29435139 | ||
SJ-GBM2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 29435139 | ||
SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 29435139 | ||
NB-EBc1 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 29435139 | ||
LAN-5 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 29435139 | ||
Rh18 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 29435139 | ||
NB1643 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells | 29435139 | ||
SK-N-MC | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells | 29435139 | ||
SJ-GBM2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells | 29435139 | ||
TC32 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells | 29435139 | ||
Rh18 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells | 29435139 | ||
Saos-2 | qHTS assay | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells | 29435139 | ||
點擊查看更多細胞系數(shù)據(jù) |
產品描述 | BI-2536是一種有效的Plk1抑制劑,無細胞試驗中IC50為0.83 nM。BI-2536可抑制 Bromodomain 4 (BRD4) ,其Kd值為37 nM,并有效地抑制 c-Myc 的表達。BI-2536可誘導凋亡而減弱自噬。Phase 2。 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
特性 | BI 2536是第一個有效的Plk1選擇性抑制劑,抑制 Plk1的標記。 | ||||||||||
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | 除了Plk1, BI 2536也抑制 Plk2 和Plk3活性,只是抑制程度低點,IC50分別為3.5 nM和9.0 nM。BI 2536比一組63種其他蛋白激酶(IC50>10 μM)選擇性高1000多倍。BI 2536 按10 nM 到 100 nM劑量作用于HeLa細胞,抑制有絲分裂中心體中γ-微管蛋白招募和Apc6 磷酸化,抑制染色體臂中釋放黏結蛋白, 誘導產生單極主軸,及一些依賴Plk1的其他有絲分裂過程。與作用于Plk1 RNAi效果相一致, BI 2536處理HeLa細胞,使細胞周期停在G2/M期, 隨后DNA分解及凋亡,且累積斷裂的PARP p85片段,這種作用存在濃度依賴性。BI 2536抑制一組32種人腫瘤細胞系生長,EC50為2-25 nM,抑制指數(shù)生長的hTERT-RPE1,人臍靜脈內皮細胞 (HUVECs),和正常大鼠腎臟(NRK) 細胞的增殖,EC50為12-31 nM。[1] BI 2536 抑制Plk1,降低甲狀腺未分化癌(ATC)細胞如 CAL62, OCUT-1, SW1736, 8505C,和 ACT-1 的生長的生長和活力,EC50為1.4-5.6 nM。[2] |
|||
---|---|---|---|---|
激酶實驗 | 體外Plk1激酶實驗 | |||
重組人Plk1 (1-603殘基) 作為氮端,攜帶桿狀病毒表達系統(tǒng)的GST-標記的融合蛋白通過親和層析,使用谷胱甘肽-瓊脂糖而純化。在梯度稀釋的BI 2536存在時,使用 20 ng 重組激酶,及10 μg牛奶中的酪蛋白作為底物進行Plk1 酶活性實驗。在終體積為60 μL 的混合物(15 mM MgCl2, 25 mM MOPS [pH 7.0], 1 mM DTT, 1% DMSO, 7.5 mM ATP, 0.3 μCi γ-33P-ATP)中30oC下進行激酶反應45分鐘。加入 125 μL 冰凍的5% TCA終止反應。沉淀物轉移到混合酯纖維素的多屏過濾板上,使用1% TCA沖洗實驗板,然后利用放射性進行測量。繪制劑量反應曲線,而計算IC50值。 | ||||
細胞實驗 | 細胞系 | HeLa, A43, SKOV-3, HT-29, K562, A549, Saos-2, MCF7, HCT116, COLO 205, Hep G2, Raji, PC-3,等等 | ||
濃度 | 溶于DMSO, 終濃度為~1 μM | |||
孵育時間 | 24,和72小時 | |||
方法 | 使用不同濃度BI 2536處理細胞24和72小時。 在熒光分光光度計中測量Alamar Blue染料轉換而測定細胞生長。為了測定培養(yǎng)基中DNA含量,細胞懸液在80%乙醇中混合, 使用溶于PBS的0.25% Triton X-100處理5分鐘,然后與0.1% RNase 和溶于PBS的 10 μg/mL碘化丙啶在室溫下溫育20分鐘。通過流式細胞儀分析而測定細胞周期譜。 |
|||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | Aurora B / pAurora B / pAurora C / pH3 / Cyclin B1 / Securin / pBcl-XL / MPM2 pPlk1 / Plk1 / pMyt1 pMEK / MEK / pERK / ERK / pRSK1 / RSK1 p-HH3 / PARP / Myc / p-Myc pro-caspase-8 / cleaved caspase-8 / cleaved caspase-3 / cleaved caspase-9 | 25169932 | ||
Immunofluorescence | Pericentrin / α-tubulin p-H2AX / propidium iodide | 21772266 | ||
Growth inhibition assay | Cell viability | 21772266 |
體內研究(In Vivo) | ||
體內研究活性 | BI 2536靜脈注射給藥多種移植瘤模型,每周一次或兩次,效果都很好,通過使細胞周期停滯而抑制細胞增殖,隨后誘導腫瘤細胞死亡。BI 2536按 50 mg/kg劑量處理HCT 116移植瘤,每周一次或兩次,顯著抑制腫瘤生長,T/C 分別為15%和0.3%。BI 2536每周處理兩次BxPC-3和A549模型,也顯著抑制腫瘤生長,T/C分別為5% 和14%。[1] |
|
---|---|---|
動物實驗 | Animal Models | 皮下注射HCT 116, NCI-H460, 或A549 細胞的雌性BomTac:NMRI-Foxn1nu 小鼠 |
Dosages | ~50 mg/kg | |
Administration | 靜脈注射,每周一到兩次 |
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT02215044 | Terminated | Pancreatic Neoplasms |
Boehringer Ingelheim |
June 2007 | Phase 1 |
NCT02211833 | Completed | Carcinoma Non-Small-Cell Lung |
Boehringer Ingelheim |
October 2006 | Phase 1 |
NCT00701766 | Completed | Leukemia Myeloid Acute |
Boehringer Ingelheim |
October 2006 | Phase 2 |
NCT00706498 | Completed | Prostatic Neoplasms |
Boehringer Ingelheim |
September 2006 | Phase 2 |
NCT00376623 | Completed | Carcinoma Non-Small-Cell Lung |
Boehringer Ingelheim |
July 25 2006 | Phase 2 |
NCT02211872 | Completed | Neoplasms |
Boehringer Ingelheim |
August 2004 | Phase 1 |
分子量 | 521.66 | 分子式 | C28H39N7O3 |
CAS號 | 755038-02-9 | SDF | Download BI 2536 SDF |
Smiles | CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 104 mg/mL ( (199.36 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 104 mg/mL (199.36 mM) Water : Insoluble |
摩爾濃度計算器 |
體內溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內配方計算器 |
動物體內配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項
問題 1:
We need to use BI 2536 in preclinical studies using mice, how to formulate the inhibitor for this in vivo study?
回答:
For in vivo study, DMSO should not be more than 5% because the toxicity. You can formulated BI2536 in hydrochloric acid (0.1 N), and diluted with 0.9% NaCl for animal study according to the reference :( Supplemental Data) http://linkinghub.elsevier.com/retrieve/pii/S0960-9822(06)02671-6